1976
DOI: 10.1093/infdis/134.5.470
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

Abstract: The Towne 125 strain of human cytomegalovirus (CMV), adapted to growth in human diploid cell strain WI-38 and propagated in this cell line for 129 consecutive passages, was administered to male volunteers with or without preexisting antibodies to CMV. Infection was not achieved by intranasal administration. In contrast, subcutaneous inoculation of virus induced seroconversion in all seronegative volunteers and a booster antibody response in some previously seropositive individuals. Transient local reactions oc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
62
0

Year Published

1978
1978
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 173 publications
(63 citation statements)
references
References 15 publications
1
62
0
Order By: Relevance
“…In fact, Penfold et al (33) have recently shown that one of the genes deleted in laboratory strains encodes for a chemokine. Clinical trials based on immunization of healthy volunteers with AD169, Towne, or Toledo strains indicate that the low passaged Toledo strain exhibits a significantly higher virulence, being able to cause clinically apparent disease (34), compared with other two highly passaged strains (35)(36)(37)(38). It is thus possible that gene products involved in the immunoescape and survival of the virus in the host are deleted in the laboratory strains (33).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, Penfold et al (33) have recently shown that one of the genes deleted in laboratory strains encodes for a chemokine. Clinical trials based on immunization of healthy volunteers with AD169, Towne, or Toledo strains indicate that the low passaged Toledo strain exhibits a significantly higher virulence, being able to cause clinically apparent disease (34), compared with other two highly passaged strains (35)(36)(37)(38). It is thus possible that gene products involved in the immunoescape and survival of the virus in the host are deleted in the laboratory strains (33).…”
Section: Discussionmentioning
confidence: 99%
“…The AD169 and Towne HCMV strains were developed as vaccine candidates by serial passages in HELFs with the intention of attenuating their virulence [43,44], thus reducing or suppressing their ability to replicate in ECs [45,46]. This line of thought was confirmed by the sequential propagation of four recent HCMV isolates in HELFs [37].…”
Section: Hcmv Leukocyte and Endothelial Cell Tropismmentioning
confidence: 99%
“…In the first group, Towne and AD169 viruses both carry a~15 kb deletion in the ULb¢ region [52], as well as various mutations in UL128L, as a result of multiple passaging in HELFs [43,44]. Thus, both Towne and AD169 have lost the ability to infect endothelial and epithelial cells and lack a functional PC.…”
Section: Development Of An Hcmv Vaccine: Potential Role Of the Pcmentioning
confidence: 99%
“…Another important aspect of CMV is infection of patients undergoing renal transplantation (for review, see Osborn, 1981). In an attempt to prevent infection by exogenous CMV, two groups of virologists initiated vaccination with live, cell culture-passaged CMV (Elek & Stern, 1974;Plotkin et al, 1976). However, since human CMV is highly speciesspecific, these vaccines have no experimental animal model in which pathogenicity and the mechanism of immunity can be studied.…”
Section: Introductionmentioning
confidence: 99%